Mandate

Vinge advises in Studentbostäder i Sverige AB’s issuance of sustainable bonds

Vinge advises in Studentbostäder i Sverige AB’s (the “Company”) issuance of a new senior unsecured sustainability bonds in an amount of SEK 500,000,000 within a framework amount of SEK 1,000,000,000 (the “Bonds”).

In connection with the transaction the Company established a sustainability bond framework in accordance with the 2018 ICMA Sustainability Bond Guidelines. The sustainability bond framework has been evaluated by an independent third party, ISS ESG, which assessed the framework and the related policy documents and reporting standards. The sustainability framework supports, among others, the UN’s global sustainable development goals; no. 7 “affordable and clean energy”, no. 11 “sustainable cities and communities” and no. 13 “climate action”.

In accordance with the terms and conditions, the Bonds are intended to be listed on the sustainable bond list of Nasdaq Stockholm. Nordea Bank Abp, Pareto Securities AB and Swedbank AB (publ) acted as joint bookrunners and arrangers in connection with the issuance of the Bonds.

Vinge’s team consisted of Mikael Ståhl, Lionardo Ojeda and Felix Möller (Banking and Finance) as well as Clara Sohlberg and David Bokliden (Capital Markets and Public M&A).

 

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024